Obese Clinical Trial
Official title:
Randomised Controlled Trial to Study the Effects of Preoperative Very Low Calorie Diet on Wound Healing in Morbidly Obese Patients Undergoing Bariatric Surgery
This study is a randomised control trial comparing the effects of a pre-operative very low
calorie diet (VLCD) on wound healing in the morbidly obese patients undergoing bariatric
surgery.
The benefits and disadvantages of a very low calorie pre-operative diet are not clear. Some
centres ask their patients to take a VLCD 2-6 weeks before bariatric surgery with the aim of
shrinking the liver to make surgery easier. Studies have shown that after this diet the
liver does shrink and therefore operating may be easier but this did not necessary translate
into significant lesser operative times. The effects of operating during a catabolic phase
have not been evaluated. Theoretically a low calorie diet before surgery is similar to
starving a patient and can potentially create a state of malnutrition. This is rarely
advisable before surgery and can lead to poor wound healing and poor healing of bowel
anastomosis.
This study will ascertain if there is any difference in wound healing rates in these
morbidly obese patients (BMI>40kg/m2)undergoing a Laparoscopic Roux en Y gastric by pass in
groups who have taken the preoperative diet compared to those who were not on a special
diet. Skin wounds will be evaluated. This will potentially reflect the general state of
healing of the patient which includes the healing of bowel anastomosis. Surrogate markers
will be employed to evaluate the pre-morbid nutritional state, effectiveness of dieting,
subsequent wound healing (collagen production, markers for the different aspects of wound
healing) and impact on liver cell death .This study will be able to tell us how safe this
calorie deficient diet is in these morbidly obese patients before surgery.
Study Design:
Prospective single blinded randomised controlled study
Null hypothesis: There is no difference in wound healing between patients on a very low
calorie diet and those not on a diet prior to a Laparoscopic Roux en Y gastric bypass
(LRYGB)
Participants:
All patients referred to King's College Hospital for weight loss surgery who are morbidly
obese (BMI>40) who undergo LRYGB will be eligible. All patients undergo an introductory
group education session after which they are counselled one to one where the patient and the
clinician decide on the most appropriate bariatric procedure. Only those who will undergo a
laparoscopic roux en y gastric bypass will be offered the opportunity to participate in the
study by a member of the research team. The study is open to all irrespective of age, sex,
ethnicity and religion.
Written information will be given in the appropriate language.
Interventions:
Diet:
Patients who meet the eligibility criteria will be placed in 2 broad groups based on whether
they smoke or not. In each group, patients will be randomly chosen in two subgroups:
Group I:taking the pre operative diet Group II:no special diet. A preoperative, low energy
diet will be used for 4 weeks. The diet contains 3 pints of semiskimmed milk. This is
equivalent to 1704 ml and provides a total intake of 800kcal, 82 g carbohydrate, 61 g
protein and 30g fat in a day. Each patient will also take multivitamin and mineral
supplementation. This will further be supplemented with a minimum of 2 litres of energy free
liquids (water, diet fizzy drinks, mineral water, black tea / coffee or squash (no added
sugar)) per day. The longterm safety and success of VLCD has been demonstrated.It does cause
shrinkage of the liver and can decrease the patients weight prior to surgery.
Data collection:
Patient characteristics and medical history will be taken
Pre diet, post diet and prior to surgery:
1. Anthropometric measurements:
Height, Weight, BMI, Hip:Waist ratio
2. Routine prediet blood tests and for routine preoperative evaluation:
This includes full blood count,Lipid profile,Renal profile,Bone profile,Liver Function
Tests
3. Serum CK 18 (M30 and M65) levels before and after the diet, which is a marker of liver
apoptosis.
4. Imaging:
1. Dual-energy X-ray absorptiometry (DEXA) scan - body composition (prediet,post diet
and at 3 months)
2. Ultrasound before and after the diet:
The length and breadth of the liver will be measured, which will allow an estimate of
the cross-section of the liver at a well defined constant point on each patient
5. Two punch biopsies (4mm) from the abdominal wall where the patient is likely to have a
laparoscopic port, before start of the diet
Per operatively:
- Elliptical excision of skin of the operating ports during the operation
- Operative difficulty score assessed by blinded surgeon and independent observer
Post operatively:
Follow up:
Patient will be followed at 1 week, 8 weeks, 3 months and then will continue to be followed
according to our usual bariatric protocol.
Wound Healing Assessment:
1. Examine all wounds and define presence of wound infection
2. Two 4 mm punch biopsies of one of the healing wounds will be taken under local
anaesthesia, at 7 days and 90 days postoperatively
;
Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Double Blind (Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Treatment
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT04105075 -
COPD in Obese Patients
|
||
Completed |
NCT04099654 -
The Effect of Core Stabilization Exercise Program in Obese Subjects Awaiting Bariatric Surgery
|
N/A | |
Recruiting |
NCT05857150 -
Exercise Response in Humans With Obesity
|
||
Completed |
NCT03532672 -
Early Effect of Fasting on Metabolic, Inflammatory, and Behavioral Responses in Females With and Without Obesity
|
N/A | |
Completed |
NCT02086448 -
Sleep Disordered Breathing, Obesity and Pregnancy Study (SOAP)
|
N/A | |
Completed |
NCT02618486 -
The Effects of Obesity on Non Surgical Periodontal Therapy
|
N/A | |
Completed |
NCT01724515 -
PGC-1 and Mitochondrial Dysfunction in Diabetes
|
N/A | |
Completed |
NCT01724502 -
Mitochondrial Dysfunction in Diabetes
|
N/A | |
Active, not recruiting |
NCT01634204 -
Efficacy of a Web-based Weight Loss Program
|
Phase 2 | |
Completed |
NCT01421589 -
Growth Hormone Treatment on Phosphocreatine Recovery in Obesity
|
N/A | |
Completed |
NCT01479933 -
Glucose Metabolism Effects of Vitamin D Supplementation in Prediabetes
|
N/A | |
Completed |
NCT03528304 -
Native Women's Wellness: Contingency Management for Tobacco Cessation and Weight Loss
|
N/A | |
Completed |
NCT01467817 -
Obesity/Overweight in Persons With Early and Chronic Spinal Cord Injury (SCI)
|
N/A | |
Completed |
NCT01726647 -
Metabolism Associated With Abdominal Fat Mass Distribution
|
N/A | |
Active, not recruiting |
NCT02125149 -
The Expecting Study
|
N/A | |
Completed |
NCT05737927 -
Pharmacodynamics and Pharmacokinetics of Different Glucose Bead Formulations in Obese Healthy Subjects
|
Phase 1 | |
Completed |
NCT05433506 -
Safety and Pharmacokinetics of HU6
|
Phase 1 | |
Completed |
NCT02871882 -
Ox Bile- Conjugated Bile Acids Sodium in Type II Diabetes Mellitus
|
Phase 2 | |
Completed |
NCT03298464 -
Study of NGM313 in Obese Participants
|
Phase 1 | |
Completed |
NCT05061173 -
Comparison of Aerobic, Resistance, and Combined Training in Overweight/Obese Hypertensive Adults
|
N/A |